CI_with has_Ingredient has_MoA has_PE may_prevent may_treat Candidiasis, Chronic Mucocutaneous [Disease/Finding] Candidiasis, Cutaneous [Disease/Finding] Candidiasis, Oral [Disease/Finding] Candidiasis, Vulvovaginal [Disease/Finding] Drug Hypersensitivity [Disease/Finding] AIDS-Related Opportunistic Infections [Disease/Finding] Nystatin [Chemical/Ingredient] Decreased Cell Wall Integrity [PE] Ergosterol Synthesis Inhibitors [MoA] [AM700] ANTIFUNGALS NYSTATIN NYSTATIN 100000UNT/ML SUSP,ORAL [VA Product] C47624 N0000149693 NYSTATIN 100000 UNT/ML SUSP NYSTATIN SUSP <VANDF_Record>50.68^897^</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>897</VA_IEN> <Product_Component>NYSTATIN</Product_Component><Strength>100000</Strength><Unit>UNIT/ML</Unit><Unit>UNT/ML</Unit><VA.IEN>173</VA.IEN> VA Product 312055 UNIT/ML 4001505 100000 C0979080 Active Nystatin 100000 UNT/ML Oral Suspension NYSTATIN 100000UNT/ML SUSP,ORAL <VANDF_Record>50.68^902^Inactive</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>902</VA_IEN><VA_Status>Inactive</VA_Status> NYSTATIN 100000UNT/ML SUSP,ORAL [VA Product] 4001505 C47624 N0000149693 NYSTATIN 100000 UNT/ML SUSP C0979080 Active 100000 NYSTATIN SUSP <VANDF_Record>50.68^897^</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>897</VA_IEN> Nystatin 100000 UNT/ML Oral Suspension <Product_Component>NYSTATIN</Product_Component><Strength>100000</Strength><Unit>UNIT/ML</Unit><Unit>UNT/ML</Unit><VA.IEN>173</VA.IEN> VA Product NYSTATIN 100000UNT/ML SUSP,ORAL <VANDF_Record>50.68^902^Inactive</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>902</VA_IEN><VA_Status>Inactive</VA_Status> 312055 UNIT/ML